Are you Dr. Viner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Rockville Pike
# 8901
Bethesda, MD 20889Phone+1 301-435-5332Fax+1 301-402-0181
Summary
- Dr. Jaye Viner, MD is an internist in Bethesda, Maryland. She is currently licensed to practice medicine in Maryland and Virginia.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
University of MarylandResidency, Internal Medicine, 1992 - 1995
University of Virginia School of MedicineClass of 1992
Certifications & Licensure
VA State Medical License 1998 - 2016
MD State Medical License 1995 - 2015
Publications & Presentations
PubMed
- 93 citationsDual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers.Kaiming Sun, Ruzanna Atoyan, Mylissa Borek, Steven DellaRocca, Maria Samson
Molecular Cancer Therapeutics. 2017-02-01 - 119 citationsSafety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma o...Anas Younes, Jesus G. Berdeja, Manish R. Patel, Ian W. Flinn, John F. Gerecitano
The Lancet. Oncology. 2016-05-01 - 49 citationsPhase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid TumorsPaul Haluska, Michael E. Menefee, Elizabeth R. Plimack, Jonathan E. Rosenberg, Donald W. Northfelt
Clinical Cancer Research. 2014-09-15
Press Mentions
CURIS : Change in Directors or Principal Officers, Other Events (Form 8-K)January 21st, 2016
